HHS-2024-IHS-SDPI-0001: Special Diabetes Program for Indians
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Indian Health Service notices from 2023.
Indian Health Service offered grants of up to $600,000 (at least $25,000) to tribes. It expected to make about 15 awards worth $10.0 million in total. Applications closed on November 29, 2023.
From the official notice on Grants.gov, last changed October 2, 2023. Checked November 7, 2026.
- Award ceiling$600,000
- Award floor$25,000
- Total funding$10.0 million
- Expected awards15
- Cost sharingNot required
- Funding typeCooperative Agreement
Other notices with this title
| Notice | Posted | Deadline | Status |
|---|---|---|---|
| HHS-2023-IHS-SDPI-0001 | July 26, 2022 | Closed October 7, 2022 | Closed |
Key dates
| Posted | October 2, 2023 |
|---|---|
| Deadline | November 29, 2023 |
| Archived by Grants.gov | December 29, 2023 |
Who can apply
This opportunity was open to tribes.
- Native American tribal governments (Federally recognized)
- Native American tribal organizations (other than Federally recognized tribal governments)
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
To be eligible for this FY 2024 funding opportunity, applicants must be one of the following as required by 42 U.S.C. 254c-3(b): • An Indian health program operated by an Indian Tribe or Tribal organization pursuant to a contract, grant, cooperative agreement, or compact with the Indian Health Service pursuant to the Indian Self-Determination and Education Assistance Act [25 U.S.C. 5321 et seq.]. • An urban Indian health program operated by an urban Indian Organization pursuant to a grant or contract with the Indian Health Service pursuant to title V of the Indian Health Care Improvement Act [25 U.S.C. 1651 et seq.]. • The Indian Health Service. Under this announcement, only one SDPI grant will be awarded per entity. If a Tribe submits an application or already has an SDPI grant, their local IHS facility cannot apply; if the Tribe does not submit an application or does not already have an SDPI grant, the IHS facility can apply. Tribes that are awarded grant funds may sub-contract with local IHS facilities to provide specific clinical services. In this case, the Tribe would be the primary SDPI grantee and the Federal entity would have a sub-contract within the Tribe’s SDPI grant. • Not a current SDPI grant recipient.
Is this a realistic fit?
- Past Special Diabetes Program for Indians Diabetes Prevention and Treatment Projects awards averaged $1.1 million; this notice allows up to $600,000 per award.
- Most of the program's money (78% over five years) went to tribes.
- No cost sharing or match is required.
What the grant funds
The purpose of this program is to provide diabetes treatment and/or prevention activities and/or services (also referred to as “activities/services”) for AI/AN communities. Recipients will implement one Special Diabetes Program for Indians (SDPI) Diabetes Best Practice (also referred to as “Best Practice”) and report data on the Best Practice’s Required Key Measure (RKM). Recipients may also implement other activities/services based on diabetes-related community needs and develop an evaluation plan. Activities/services will be aimed at reducing the risk of diabetes in at-risk individuals, providing high quality care to those with diagnosed diabetes, and/or reducing the complications of diabetes.
Who has won Special Diabetes Program for Indians Diabetes Prevention and Treatment Projects grants before
From fiscal 2021 to 2025, Special Diabetes Program for Indians Diabetes Prevention and Treatment Projects (93.237) awarded $624 million across 567 grant awards, an average of $1.1 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Indian Health Service | Arizona | 2 | $36.1 million |
| Cherokee Nation | Oklahoma | 2 | $34.9 million |
| Navajo Nation Tribal Government | Arizona | 1 | $19.3 million |
| Gila River Healthcare Corporation | Arizona | 2 | $17.3 million |
| Choctaw Nation of Oklahoma | Oklahoma | 2 | $17.2 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is HHS-2024-IHS-SDPI-0001 still open?
No. It closed on November 29, 2023.
Who can apply for Special Diabetes Program for Indians?
Indian Health Service accepted applications from tribes. The notice adds further conditions, so read its eligibility section.
What is the deadline for Special Diabetes Program for Indians?
Closed November 29, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $600,000 each. About $10.0 million in total across about 15 awards.
Who has won Special Diabetes Program for Indians Diabetes Prevention and Treatment Projects grants before?
The largest recipients over five fiscal years were Indian Health Service, Cherokee Nation, Navajo Nation Tribal Government. The program made 567 awards worth $624 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)